132
Views
51
CrossRef citations to date
0
Altmetric
Original Research

Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD

, , , , , , , , , , & show all
Pages 2029-2034 | Published online: 26 Aug 2016

References

  • TanWSPehHYLiaoWCigarette smoke-induced lung disease predisposes to more severe infection with nontypeable haemophilus influenzae: protective effects of andrographolideJ Nat Prod20167951308131527104764
  • SuBLiuTFanHInflammatory markers and the risk of chronic obstructive pulmonary disease: a systematic review and meta-analysisPLoS One2016114e015058627104349
  • BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
  • OwensRLMalhotraASleep-disordered breathing and COPD: the overlap syndromeRespir Care2010551333134420875160
  • GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
  • AgustiASorianoJBCOPD as a systemic diseaseCOPD20085213313818415812
  • YanZQHanssonGKInnate immunity, macrophage activation, and atherosclerosisImmunol Rev200721918720317850490
  • FrostegårdJUlfgrenAKNybergPCytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokinesAtherosclerosis19991451334310428293
  • SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
  • ManninoDMDohertyDESonia BuistAGlobal Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) studyRespir Med2006100111512215893923
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
  • CelliBDecramerMLeimerIVogelUKestenSTashkinDPCardiovascular safety of tiotropium in patients with COPDChest20101371203019592475
  • IsoHNodaHIkedaAThe impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based studyJ Atheroscler Thromb201219875676622785140
  • RidkerPMCushmanMStampferMJTracyRPHennekensCHPlasma concentration of C-reactive protein and risk of developing peripheral vascular diseaseCirculation19989754254289490235
  • RidkerPMCushmanMStampferMJTracyRPHennekensCHInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy menN Engl J Med1997336149739799077376
  • MashibaSWadaYTakeyaMIn vivo complex formation of oxidized alpha (1)-antitrypsin and LDLArterioscler Thromb Vasc Biol200121111801180811701469
  • KomiyamaMWadaHUraSThe effects of weight gain after smoking cessation on atherogenic α1-antitrypsin-low-density lipoproteinHeart Vessels201530673473925086816
  • OgasawaraKMashibaSWadaYA serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery diseaseAtherosclerosis2004174234935615136066
  • MenonVPSudheerARAntioxidant and anti-inflammatory properties of curcuminAdv Exp Med Biol200759510512517569207
  • ZhouHBeeversCSHuangSThe targets of curcuminCurr Drug Targets201112333234720955148
  • ShimatsuAKakeyaHImaizumiAMorimotoTKanaiMMaedaSClinical application of “curcumin”, a multi-functional substanceAnti-Aging Med201294351
  • MorimotoTSunagawaYKawamuraTThe dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in ratsJ Clin Invest2008118386887818292809
  • SasakiHSunagawaYTakahashiKInnovative preparation of curcumin for improved oral bioavailabilityBiol Pharm Bull201134566066521532153
  • FanZYaoJLiYHuXShaoHTianXAnti-inflammatory and antioxidant effects of curcumin on acute lung injury in a rodent model of intestinal ischemia reperfusion by inhibiting the pathway of NF-KbInt J Clin Exp Pathol2015843451345926097529
  • EngströmGLindPHedbladBLung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteinsCirculation2002106202555256012427651
  • CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol2006161637016039877
  • SalpeterSROrmistonTMSalpeterEECardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysisChest200412562309232115189956
  • SouvereinPCBerardAVan StaaTPUse of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control studyHeart200490885986515253953
  • WadaHUraSSatoh-AsaharaNα1-Antitrypsin low-density-lipoprotein serves as a marker of smoking-specific oxidative stressJ Atheroscler Thromb2012191475822027559
  • GhoshSBanerjeeSSilPCThe beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent updateFood Chem Toxicol20158311112426066364
  • HeYYueYZhengXZhangKChenSDuZCurcumin, inflammation, and chronic diseases: how are they linked?Molecules20152059183921326007179
  • MengBLiJCaoHAntioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complicationsCurr Pharm Des201319112101211323116316
  • JoeBLokeshBRRole of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophagesBiochim Biophys Acta1994122422552637981240
  • SøysethVBrekkePHSmithPOmlandTStatin use is associated with reduced mortality in COPDEur Respir J200729227928317050558
  • MortensenEMCopelandLAPughMJImpact of statins and ACE inhibitors on mortality after COPD exacerbationsRespir Res2009104519493329